Abbott Laboratories (ABT) Financial Ratios: P/E, ROE & More

Abbott Laboratories (ABT) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Abbott Laboratories had a P/E ratio of 33.52 (up from 14.64), return on equity of 13.0% (down from 30.9%), debt-to-equity of 0.27 (down from 0.32) and a current ratio of 1.58 (down from 1.67). A current ratio of 1.58 means current assets exceed current liabilities. Its dividend yield was 1.91% with a payout ratio of 63.1%.

Abbott Laboratories Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Income Statement Balance Sheet Cash Flow Ratios

Scroll to see more

Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Valuation Ratios
P/E Ratio	33.52	14.64	33.52	27.72	34.27	41.94
Forward P/E	22.63	22.39	24.22	26.64	30.05	23.93
P/S Ratio	4.92	4.68	4.76	4.38	5.60	5.42
P/B Ratio	4.13	4.10	4.92	5.19	6.70	5.68
Price/Tangible Book	9.65	10.96	31.28	55.76	-	-
Price/FCF	29.46	30.89	37.77	24.53	27.91	32.77
Price/OCF	22.77	22.92	26.32	19.98	22.91	23.74
PEG Ratio	2.35	2.61	2.85	5.16	2.38	2.06
Enterprise Value Ratios
EV/Revenue	5.04	4.86	4.99	4.54	5.81	5.83
EV/EBITDA	18.57	19.01	19.11	16.02	19.64	22.94
EV/EBIT	25.05	27.17	27.69	21.76	27.19	36.92
EV/FCF	30.21	32.07	39.52	25.41	28.94	35.23
Profitability & Returns
Return on Equity (ROE)	12.96%	30.91%	15.11%	19.01%	20.49%	13.91%
Return on Assets (ROA)	6.63%	6.06%	6.11%	7.61%	7.79%	4.86%
Return on Invested Capital (ROIC)	12.14%	14.59%	13.45%	16.96%	17.46%	10.69%
Return on Capital Employed (ROCE)	12.70%	11.10%	12.20%	15.50%	14.80%	9.00%
Leverage & Solvency Ratios
Debt/Equity	0.27	0.32	0.41	0.49	0.53	0.60
Debt/EBITDA	1.14	1.38	1.48	1.41	1.47	2.18
Debt/FCF	1.91	2.41	3.16	2.30	2.23	3.48
Liquidity Ratios
Current Ratio	1.58	1.67	1.64	1.63	1.85	1.72
Quick Ratio	1.02	1.05	1.00	1.06	1.28	1.14
Efficiency Ratios
Asset Turnover	0.53	0.54	0.54	0.58	0.58	0.49
Inventory Turnover	3.03	2.92	2.81	3.37	3.56	3.22
Yield & Distribution Ratios
Earnings Yield	3.00%	6.83%	3.00%	3.62%	2.93%	2.40%
FCF Yield	3.39%	3.24%	2.65%	4.08%	3.58%	3.05%
Dividend Yield	1.91%	1.98%	1.89%	1.74%	1.33%	1.54%
Payout Ratio	63.09%	28.62%	62.14%	47.73%	45.28%	56.95%
Buyback Yield	-0.06%	0.06%	0.85%	1.40%	-0.17%	-0.28%
Total Return	1.86%	2.03%	2.74%	3.14%	1.16%	1.26%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Abbott Laboratories Financial Ratios

What is Abbott Laboratories's P/E ratio?

Abbott Laboratories's P/E ratio was 33.52 for fiscal 2025 (period ended Dec 31, 2025). It was 14.64 a year earlier.

What is Abbott Laboratories's return on equity?

Abbott Laboratories's return on equity (ROE) was 13.0% for fiscal 2025 (period ended Dec 31, 2025). It was 30.9% a year earlier.

What is Abbott Laboratories's debt-to-equity ratio?

Abbott Laboratories's debt-to-equity ratio was 0.27 for fiscal 2025 (period ended Dec 31, 2025). It was 0.32 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition